Acute pulmonary embolism is the third leading cause of cardiovascular death, with most
pulmonary embolism–related mortality associated with acute right ventricular failure …

There is a growing clinical and scientific interest in catheter-directed therapy (CDT) of acute
pulmonary embolism (PE). Currently, CDT should be considered for patients with high-risk …

Severe forms of pulmonary embolism (PE) in children, althought rare, cause significant
morbidity and mortality. We review the pathophysiologic features of severe (high-risk and …

Introduction: Massive acute pulmonary embolism (MAPE) with obstructive cardiogenic shock
is associated with a mortality rate of more than 50%. Venoarterial extracorporeal membrane …

Massive pulmonary embolism (MPE) carries significant 30-day mortality and is characterized
by acute right ventricular failure, hypotension, and hypoxia, leading to cardiovascular …

Acute pulmonary embolism (PE) is a leading cause of modern cardiovascular morbidity and
mortality. While both acute PE and acute coronary syndrome (ACS) both reflect arterial …

High-risk pulmonary embolism (PE) also known as massive PE carries a high rate of
morbidity and mortality. The incidence of high-risk PE continues to increase, yet the …

High-risk acute pulmonary embolism (PE), defined as acute PE associated with
hemodynamic instability, remains a significant contributor to cardiovascular morbidity and …

High-risk/massive pulmonary embolism (PE) has a high mortality rate, especially when
cardiac arrest occurs. Venoarterial (VA) extracorporeal membrane oxygenation (ECMO) can …

Surgical science has driven innovation and inquiry across adult and pediatric disciplines
that provide critical care regardless of location. Surgically originated but broadly applicable …